MICROVISION, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MICROVISION, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jan 31, 2023 | $2.30M | Mar 26, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Mar 2, 2023 |
| FY2022 | Sep 30, 2022 | $0 | Mar 2, 2023 |
| FY2022 | Jun 30, 2022 | $314.0K | Mar 2, 2023 |
| FY2022 | Mar 31, 2022 | $350.0K | Mar 2, 2023 |
| FY2022 | Dec 31, 2021 | $557.0K | Mar 2, 2023 |
| FY2022 | Sep 30, 2021 | $718.0K | Mar 2, 2023 |
| FY2022 | Jun 30, 2021 | $746.0K | Mar 2, 2023 |
| FY2022 | Mar 31, 2021 | $479.0K | Mar 2, 2023 |
| FY2022 | Dec 31, 2020 | $395.0K | Mar 2, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $4.70M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $7.26M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $664.0K | Mar 26, 2025 |
| FY2023 | Dec 31, 2021 | $2.50M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $3.09M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $8.89M | Mar 1, 2022 |
| FY2019 | Dec 31, 2018 | $17.61M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $9.63M | Mar 6, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($94.98M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($96.92M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | ($82.84M) | Mar 4, 2026 |
| FY2024 | Jan 31, 2023 | $3.90M | Mar 26, 2025 |
| FY2022 | Dec 31, 2022 | ($13.48M) | Mar 2, 2023 |
| FY2022 | Sep 30, 2022 | ($12.85M) | Mar 2, 2023 |
| FY2022 | Jun 30, 2022 | ($13.60M) | Mar 2, 2023 |
| FY2022 | Mar 31, 2022 | ($13.17M) | Mar 2, 2023 |
| FY2022 | Dec 31, 2021 | ($12.63M) | Mar 2, 2023 |
| FY2022 | Sep 30, 2021 | ($9.38M) | Mar 2, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($82.83M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($85.52M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | ($88.88M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | ($53.89M) | Mar 26, 2025 |
| FY2023 | Dec 31, 2021 | ($43.87M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($13.62M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | ($26.47M) | Mar 1, 2022 |
| FY2019 | Dec 31, 2018 | ($27.22M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($25.48M) | Mar 6, 2019 |
| FY2017 | Dec 31, 2016 | ($16.46M) | Feb 23, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.12M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $121.16M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $129.64M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $115.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $130.23M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $21.01M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $11.84M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $23.03M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $29.77M | Mar 6, 2019 |
| FY2017 | Dec 31, 2016 | $20.11M | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.57M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $72.39M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $33.83M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $25.26M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $17.47M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $12.00M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $15.81M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $18.92M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $19.68M | Mar 6, 2019 |
| FY2017 | Dec 31, 2016 | $12.63M | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.55M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $48.77M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $95.80M | Mar 4, 2026 |
| FY2025 | Dec 31, 2022 | $89.74M | Mar 4, 2026 |
| FY2024 | Dec 31, 2021 | $112.75M | Mar 26, 2025 |
| FY2023 | Dec 31, 2020 | $9.01M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | ($3.98M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2018 | $4.12M | Mar 1, 2022 |
| FY2019 | Dec 31, 2017 | $10.09M | Mar 12, 2020 |
| FY2018 | Dec 31, 2016 | $13.94M | Mar 6, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 4, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Mar 2, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 2, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Mar 2, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 2, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 2, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 2, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 2, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 4, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Mar 2, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 2, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Mar 2, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 2, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 2, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 2, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 2, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.36M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $54.49M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $45.17M | Mar 4, 2026 |
| FY2022 | Jan 31, 2023 | $18.50M | Mar 2, 2023 |
| FY2024 | Dec 31, 2022 | $20.54M | Mar 26, 2025 |
| FY2023 | Dec 31, 2021 | $82.65M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $16.86M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $5.84M | Mar 1, 2022 |
| FY2019 | Dec 31, 2018 | $13.77M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $16.97M | Mar 6, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.21M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $33.00M | Mar 4, 2026 |